Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Cheng

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 31, 2007
Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancerGary M Freedman, Neal J Meropol, Elin R Sigurdson, et al.
Acta Oncologica (Stockholm, Sweden)|February 22, 2020
Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smokingJacob K Lilja-Fischer, Jesper G Eriksen, Jeanette B Georgsen, et al.
Gastrointestinal Cancer Research : GCR|November 2, 2011
Decreased Posttreatment SUV on PET Scan Is Associated With Improved Local Control in Medically Inoperable Esophageal CancerNavesh K Sharma, Joshua S Silverman, Tianyu Li, et al.
Head & Neck|March 5, 2004
Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollmentRobert A Schnoll, Randi L Rothman, Caryn Lerman, et al.
Psycho-Oncology|May 11, 2004
Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patientsRobert A Schnoll, Randi L Rothman, Holly Newman, et al.
Scientific Reports|November 1, 2017
Asymmetric Sensory-Motor Regeneration of Transected Peripheral Nerves Using Molecular Guidance CuesSanjay Anand, Vidhi Desai, Nesreen Alsmadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in CancerJennifer H Yearley, Christopher Gibson, Ni Yu, et al.
Head & Neck|February 19, 2005
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studiesNoel M Kramer, Eric M Horwitz, Jonathan Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b StudyKevin J Harrington, Anthony Kong, Nicolas Mach, et al.
Journal of Neural Engineering|October 22, 2020
A bioelectric neural interface towards intuitive prosthetic control for amputeesAnh Tuan Nguyen, Jian Xu, Ming Jiang, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|March 31, 2007
Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancerGary M Freedman, Neal J Meropol, Elin R Sigurdson, et al.
Acta Oncologica (Stockholm, Sweden)|February 22, 2020
Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smokingJacob K Lilja-Fischer, Jesper G Eriksen, Jeanette B Georgsen, et al.
Gastrointestinal Cancer Research : GCR|November 2, 2011
Decreased Posttreatment SUV on PET Scan Is Associated With Improved Local Control in Medically Inoperable Esophageal CancerNavesh K Sharma, Joshua S Silverman, Tianyu Li, et al.
Head & Neck|March 5, 2004
Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollmentRobert A Schnoll, Randi L Rothman, Caryn Lerman, et al.
Psycho-Oncology|May 11, 2004
Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patientsRobert A Schnoll, Randi L Rothman, Holly Newman, et al.
Scientific Reports|November 1, 2017
Asymmetric Sensory-Motor Regeneration of Transected Peripheral Nerves Using Molecular Guidance CuesSanjay Anand, Vidhi Desai, Nesreen Alsmadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in CancerJennifer H Yearley, Christopher Gibson, Ni Yu, et al.
Head & Neck|February 19, 2005
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studiesNoel M Kramer, Eric M Horwitz, Jonathan Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b StudyKevin J Harrington, Anthony Kong, Nicolas Mach, et al.
Journal of Neural Engineering|October 22, 2020
A bioelectric neural interface towards intuitive prosthetic control for amputeesAnh Tuan Nguyen, Jian Xu, Ming Jiang, et al.
Pageof 8